Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNES
SNES logo

SNES Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.900
Open
1.840
VWAP
1.84
Vol
22.50K
Mkt Cap
9.65M
Low
1.810
Amount
41.48K
EV/EBITDA(TTM)
--
Total Shares
5.30M
EV
2.99M
EV/OCF(TTM)
--
P/S(TTM)
3.46
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Show More

Events Timeline

(ET)
2026-05-12
16:20:00
SenesTech Reports Q1 Revenue of $493,000
select
2026-05-07 (ET)
2026-05-07
08:40:00
SenesTech Appoints Michael Edell as CEO
select
2026-03-12 (ET)
2026-03-12
16:20:00
Company Reports Q4 Revenue of $421M, CEO Highlights Significant Progress in 2025
select
2026-02-18 (ET)
2026-02-18
09:00:00
SenesTech Reports Significant Reductions in Rodent Activity
select
2026-01-28 (ET)
2026-01-28
16:30:00
SenesTech CEO Joel Fruendt Announces Retirement
select
2025-11-10 (ET)
2025-11-10
16:24:14
SenesTech announces Q3 earnings per share of 28 cents compared to a loss of $2.07 in the previous year.
select
2025-09-10 (ET)
2025-09-10
08:02:41
SenesTech Announces Availability of Evolve Rat Birth Control Product on HomeDepot.com
select
2025-08-05 (ET)
2025-08-05
08:08:09
SenesTech announces warrant exercise for $6.3M in gross proceeds
select
2025-07-01 (ET)
2025-07-01
08:02:13
SenesTech exercises warrants for $4.4M in gross proceeds
select

News

PRnewswire
1.0
05-19PRnewswire
SenesTech to Participate in 2026 Investor Conference
  • Webcast Schedule: SenesTech will host a webcast on May 28, 2026, at 2:30 p.m. ET, accessible via the conference homepage, enhancing investor engagement and transparency.
  • One-on-One Meeting Opportunities: Management will participate in virtual one-on-one meetings during the event, allowing investors to arrange discussions with the company, aimed at strengthening relationships and driving funding opportunities.
  • Commitment to Product Innovation: SenesTech focuses on managing animal pest populations through fertility control, with its Evolve product effectively integrated into pest management programs, reducing reliance on traditional poisons and reflecting the company's strategic commitment to sustainability.
  • Forward-Looking Statement Caution: The press release includes forward-looking statements regarding market acceptance, financial performance, and product commercialization risks, advising investors to consider potential uncertainties for informed investment decisions.
Newsfilter
1.0
05-19Newsfilter
SenesTech to Participate in 2026 Investor Conference
  • Investor Conference Participation: SenesTech will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026, with a webcast presentation scheduled for 2:30 PM ET, aimed at enhancing the company's visibility among investors and attracting potential investment.
  • One-on-One Meeting Opportunities: Management will engage in virtual one-on-one meetings throughout the event, allowing investors to arrange discussions with the team, which helps strengthen investor relations and delve into the company's strategies and future plans.
  • Commitment to Product Innovation: SenesTech focuses on managing animal pest populations through fertility control, with products like Evolve rodent birth control designed to reduce reliance on traditional poisons, thereby enhancing pest management effectiveness and promoting sustainability and environmental health.
  • Forward-Looking Statement Risks: The press release includes forward-looking statements regarding market acceptance, financial performance, and product commercialization, indicating that the company faces uncertainties in achieving growth objectives, which investors should carefully consider when assessing potential risks.
seekingalpha
9.5
05-13seekingalpha
SenesTech Q1 2026 Earnings Call Insights
  • Direct-to-Consumer Growth: SenesTech reported a 42% increase in direct-to-consumer revenue for Q1, reaching a record $194,000, indicating strong performance in this core growth engine and expected to further drive overall revenue growth.
  • E-commerce Sales Surge: Following the direct management of its Amazon account, April e-commerce sales soared 163% to $146,000, demonstrating early success in the company's e-commerce transformation and potential for continued market share expansion.
  • Strong Financial Performance: Total revenue for Q1 was $493,000, despite approximately $443,000 in one-time expenses, with gross margin improving to 68.6%, reflecting enhanced cost control and profitability, which strengthens future financial flexibility.
  • Strategic Execution Priority: Management emphasized that “commercial execution at scale” is the current central priority, with plans to expand the Evolve brand and launch new products, showcasing the company's proactive positioning in the competitive landscape and confidence in future growth.
PRnewswire
9.5
05-12PRnewswire
SenesTech Reports Strong E-Commerce Transition Results in Q1 2026
  • E-Commerce Transition Success: Under the leadership of new CEO Michael Edell, SenesTech's direct-to-consumer revenue surged 42% to a record $194,000 in Q1, reflecting strong market demand and growth potential as the company transitions to in-house Amazon management.
  • Record Gross Margin: The gross margin reached a historic high of 68.6% in Q1, indicating significant progress in operational optimization and cost control, thereby laying a solid foundation for sustainable future growth.
  • Accelerating Subscription Sales: With direct control over e-commerce channels, subscription sales have continued to accelerate, breaking previous revenue records and demonstrating increasing consumer acceptance of non-toxic rodent management solutions, enhancing the company's competitive position.
  • Strategic Investment Focus: Edell emphasized that by improving customer experience and conversion rates, SenesTech is building a more predictable recurring revenue model aimed at achieving sustainable business growth in the long term, aligning with the company's strategic vision for future markets.
PRnewswire
9.5
05-07PRnewswire
SenesTech to Release Q1 2026 Financial Results
  • Earnings Release Schedule: SenesTech is set to announce its Q1 2026 financial results after market close on May 12, 2026, reflecting the company's ongoing commitment to managing animal pest populations.
  • Conference Call Timing: A conference call will be held on the same day at 5:00 PM ET to review the financial results, aimed at enhancing investor understanding and confidence in the company's performance.
  • Live Webcast Information: Interested parties can access the conference call via a live webcast available in the Investor Relations section of the company's website, ensuring transparency and fostering investor engagement.
  • Product Mission: SenesTech is dedicated to improving environments through humane birth control products, highlighting its innovation in reducing reliance on traditional poisons and showcasing the company's strategic positioning in sustainability.
Newsfilter
9.5
05-07Newsfilter
SenesTech to Release Q1 2026 Financial Results and Host Conference Call
  • Financial Report Schedule: SenesTech will release its Q1 2026 financial results after market close on May 12, 2026, reflecting the company's ongoing commitment to transparency in animal pest management.
  • Conference Call Timing: On the same day, SenesTech will hold a conference call at 5:00 PM ET to discuss the financial results in detail and engage with investors, thereby enhancing investor confidence.
  • Live Webcast Information: Interested parties can access the conference call via a live webcast available on the company's Investor Relations page, ensuring broad participation and information dissemination to boost corporate transparency.
  • Company Mission and Vision: SenesTech is dedicated to improving environments through humane birth control products, reducing reliance on traditional poisons, and promoting sustainability, showcasing its leadership position in the industry.
Wall Street analysts forecast SNES stock price to rise
1 Analyst Rating
Wall Street analysts forecast SNES stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
10.00
High
10.00
Current: 0.000
sliders
Low
10.00
Averages
10.00
High
10.00
No data

No data

Valuation Metrics

The current forward P/E ratio for Senestech Inc (SNES.O) is 3.40, compared to its 5-year average forward P/E of -0.90. For a more detailed relative valuation and DCF analysis to assess Senestech Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.90
Current PE
3.40
Overvalued PE
0.18
Undervalued PE
-1.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.49
Current EV/EBITDA
-0.23
Overvalued EV/EBITDA
0.55
Undervalued EV/EBITDA
-1.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.50
Current PS
1.75
Overvalued PS
7.95
Undervalued PS
-0.95

Financials

AI Analysis
Annual
Quarterly

Whales Holding SNES

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Senestech Inc (SNES) stock price today?

The current price of SNES is 1.82 USD — it has increased 0.55

What is Senestech Inc (SNES)'s business?

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

What is the price predicton of SNES Stock?

Wall Street analysts forecast SNES stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNES is10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Senestech Inc (SNES)'s revenue for the last quarter?

Senestech Inc revenue for the last quarter amounts to 493.00K USD, increased 1.65

What is Senestech Inc (SNES)'s earnings per share (EPS) for the last quarter?

Senestech Inc. EPS for the last quarter amounts to -0.39 USD, decreased -69.53

How many employees does Senestech Inc (SNES). have?

Senestech Inc (SNES) has 23 emplpoyees as of May 27 2026.

What is Senestech Inc (SNES) market cap?

Today SNES has the market capitalization of 9.65M USD.